InterveXion and UAMS Complete FirstDrug Tests in Humans for Methamphetamine Addiction
Wednesday, December 19, 2012 - 09:30
in Health & Medicine
InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight their addictions.